WuXi AppTec Competitors

Olink Holding AB (publ) (NASDAQ:OLK) and WuXi AppTec (OTCMKTS:WUXIF) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Profitability

This table compares Olink Holding AB (publ) and WuXi AppTec's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Olink Holding AB (publ) and WuXi AppTec's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Olink Holding AB (publ) and WuXi AppTec, as reported by MarketBeat.

Summary

WuXi AppTec beats Olink Holding AB (publ) on 1 of the 1 factors compared between the two stocks.

Ortho Clinical Diagnostics (NASDAQ:OCDX) and WuXi AppTec (OTCMKTS:WUXIF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Profitability

This table compares Ortho Clinical Diagnostics and WuXi AppTec's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Ortho Clinical Diagnostics and WuXi AppTec's gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of recent recommendations for Ortho Clinical Diagnostics and WuXi AppTec, as provided by MarketBeat.com.

Ortho Clinical Diagnostics presently has a consensus target price of $24.2727, indicating a potential upside of 30.99%. Given Ortho Clinical Diagnostics' higher probable upside, analysts clearly believe Ortho Clinical Diagnostics is more favorable than WuXi AppTec.

Summary

Ortho Clinical Diagnostics beats WuXi AppTec on 2 of the 3 factors compared between the two stocks.

Biodesix (NASDAQ:BDSX) and WuXi AppTec (OTCMKTS:WUXIF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Profitability

This table compares Biodesix and WuXi AppTec's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Biodesix and WuXi AppTec's gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of recent recommendations for Biodesix and WuXi AppTec, as provided by MarketBeat.com.

Biodesix presently has a consensus target price of $26.00, indicating a potential upside of 34.23%. Given Biodesix's higher probable upside, analysts clearly believe Biodesix is more favorable than WuXi AppTec.

Summary

Biodesix beats WuXi AppTec on 2 of the 2 factors compared between the two stocks.

WuXi AppTec (OTCMKTS:WUXIF) and Lucira Health (NASDAQ:LHDX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Profitability

This table compares WuXi AppTec and Lucira Health's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares WuXi AppTec and Lucira Health's revenue, earnings per share and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for WuXi AppTec and Lucira Health, as provided by MarketBeat.

Lucira Health has a consensus target price of $9.00, indicating a potential upside of 14.80%. Given Lucira Health's higher probable upside, analysts plainly believe Lucira Health is more favorable than WuXi AppTec.

Summary

Lucira Health beats WuXi AppTec on 2 of the 3 factors compared between the two stocks.

WuXi AppTec (OTCMKTS:WUXIF) and Inotiv (NASDAQ:NOTV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for WuXi AppTec and Inotiv, as provided by MarketBeat.

Profitability

This table compares WuXi AppTec and Inotiv's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares WuXi AppTec and Inotiv's revenue, earnings per share and valuation.

Summary

WuXi AppTec beats Inotiv on 1 of the 1 factors compared between the two stocks.

Akumin (NASDAQ:AKU) and WuXi AppTec (OTCMKTS:WUXIF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

Earnings & Valuation

This table compares Akumin and WuXi AppTec's revenue, earnings per share and valuation.

Profitability

This table compares Akumin and WuXi AppTec's net margins, return on equity and return on assets.

Institutional and Insider Ownership

30.4% of Akumin shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Akumin and WuXi AppTec, as provided by MarketBeat.com.

Summary

Akumin beats WuXi AppTec on 1 of the 1 factors compared between the two stocks.